Vasohibin: A Potential Drug Target and Biomarker (P45356)

Target Name: Vasohibin

NCBI ID: P45356

Vasohibin

Other Name(s): Tubulinyl-Tyr carboxypeptidase | VASH

Vasohibin: A Potential Drug Target and Biomarker

Vasohibin (Tubulinyl-Tyr carboxypeptidase) is a protein that is expressed in various tissues throughout the body, including muscle, nerve, and brain cells. It is a key enzyme in the metaphylactic pathway, a critical pathway that is involved in the transport of synthesized proteins to their final destinations. In addition to its role in cell signaling, vasohibin has also been shown to have potential as a drug target or biomarker.

The metaphylactic pathway is a complex process that involves the delivery of synthesized proteins to their final destinations, such as the cell surface or other intracellular structures. This process is critical for the proper functioning of many biological processes, including cell signaling, development, and growth. One of the key enzymes involved in this pathway is vasohibin.

Vasohibin is a protein that is expressed in various tissues throughout the body, including muscle, nerve, and brain cells. It is a member of the tyrosine proteases family 11, which includes enzymes that are involved in the detoxification of tyrosine, a key precursor of many signaling proteins.

In addition to its role in cell signaling, vasohibin has also been shown to have potential as a drug target or biomarker. One of the main reasons for its potential as a drug target is its unique structure. Vasohibin is a monoclonal antibody, which means that it is a single, long-lived molecule that is produced by the immune system. This allows for the production of a highly specific and potent anti-vasohibin antibody that can be used to target the protein.

In addition to its potential as an anti-vasohibin antibody, vasohibin has also been shown to have potential as a biomarker for various diseases. For example, vasohibin has been shown to be elevated in the blood of individuals with certain types of cancer, which could make it a potential marker for the disease. Additionally, vasohibin has been shown to be decreased in the brain of individuals with certain neurological disorders, which could make it a potential biomarker for these conditions.

Another potential use for vasohibin as a drug target is its role in the development and progression of certain diseases. For example, vasohibin has been shown to be decreased in the brain of individuals with Alzheimer's disease, which could make it a potential marker for the disease. Additionally, vasohibin has been shown to be increased in the brain of individuals with certain psychiatric disorders, which could make it a potential biomarker for these conditions.

In conclusion, vasohibin is a unique and highly specific protein that is involved in the metaphylactic pathway. In addition to its role in cell signaling, vasohibin has also been shown to have potential as a drug target or biomarker for various diseases. Further research is needed to fully understand the potential of vasohibin as a drug and biomarker.

Protein Name: Vasohibin (nonspecified Subtype)

The "Vasohibin Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Vasohibin comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets